A conceptual framework linking platelet activation, adaptive FGF21-GDF15 signaling, and islet vascular dysfunction in progressive β-cell failure of type 2 diabetes.
Level 5 - mechanism / opinion, no new human data
Narrative review and theoretical mechanism-based framework without new empirical data.
PubMed 42570773 · doi:10.1016/j.diabres.2026.113486
What was done
This is a narrative review and hypothesis-generating conceptual framework. The authors synthesized existing experimental and clinical literature to describe how platelet activation, fibroblast growth factor 21 (FGF21), and growth differentiation factor 15 (GDF15) signaling pathways may interact and contribute to islet microvascular injury and progressive β-cell failure in type 2 diabetes mellitus.
What was found
The abstract reports no empirical data, sample sizes, or quantitative effect estimates. It outlines a proposed pathway in which activated platelets drive vascular inflammation and endothelial dysfunction via soluble factors and extracellular vesicles, while FGF21 and GDF15 act as adaptive stress responses to protect mitochondrial and endothelial integrity. The authors hypothesize that chronic metabolic stress ultimately impairs these adaptive responses within the islet microenvironment, driving β-cell failure.
Why it matters
This framework expands the understanding of type 2 diabetes progression beyond classical glucotoxicity and lipotoxicity to include systemic vascular and stress-response pathways, highlighting candidate targets for future mechanistic studies and biomarker development.
Limits
As a conceptual narrative review, the paper provides no new empirical or quantitative data. As noted in the abstract, direct mechanistic evidence confirming the convergence of these specific pathways in human pancreatic islets remains limited.
Cited by
- supports GDF15 is secreted by cells in response to mitochondrial dysfunction or when cellular energy consumption exceeds sustainable levels.